Born of a collaboration between three longtime colleagues with years of experience in the CRO industry, PharPoint Research offers clients both expertise and industry-best customer service. PharPoint is a privately-held CRO that was founded on the shared belief that sound business ethics and profit are not mutually exclusive.
PharPoint’s founders have used this approach to build an organization reflective of their personal work ethic and passion for improving therapies around the world, not just the bottom line. Today, PharPoint’s executive team works with senior management to continue pushing strategic innovation, industry-best customer service, and high quality in all we do.
Art Holmes, President and CEO
Mr. Holmes has acquired over 26 years of experience in the pharmaceutical industry, including extensive experience in pharmaceutical consulting and contract services.
Prior to PharPoint, he founded Databasics Consulting, Inc., a company specializing in systems implementation and validation for pharmaceutical and biotechnology clients.
Mr. Holmes has also held management positions at Quintiles Transnational Corp. and PharmaResearch Inc, subsequently known as Kendle International. In his capacity with these companies, he provided leadership in both technical and operational strategies.
Audra McRae, Chief Operating Officer
Ms. McRae’s 24 years of experience in clinical research include both laboratory research and various aspects of clinical trial oversight.
Ms. McRae began her career in academic and healthcare research. After working at North Carolina State University and Roche Biomedical, Ms. McRae began her career in the contract research (CRO) industry where she held various positions with startup and large CROs. Ms. McRae began her industry training in biometric services and has provided biometric expertise at various levels for hundreds of clinical trials during her career. Since beginning her career in the CRO industry, Ms. McRae has played an active role in multiple acquisitions and mergers and has also been integral in the development and success of two start-up CROs.
For well over two decades, Ms. McRae has held various senior management positions in the industry, most recently as Co-founder and Chief Operating Officer of PharPoint Research. She is passionate about finding solutions that improve the drug development process and helping bring great therapies to patients that need them.
Ms. McRae is active in professional and charitable organizations and has served on the Board of Directors for multiple organizations.
Jennifer A. Elder, PhD, Chief Scientific Officer
Dr. Elder has performed statistical analyses for clinical trials for 24 years.
Dr. Elder served as the lead statistician on pivotal studies for two novel compounds in a new class of antiretroviral medications in indications for the treatment of HIV and viral hepatitis. She participated in the completion of several NDA, MAA, sNDA, and IND applications and provided strategic consulting, clinical program development planning, and statistical analysis oversight for 75+ projects. Additionally, her experience includes providing statistical support for several pharmaceutical industry-sponsored pregnancy registries and phase I through IV clinical trials.
Prior to her CRO experience, Dr. Elder was an Assistant Professor of Biostatistics and a statistical consultant at the University of North Carolina at Wilmington where she maintains an adjunct affiliation. Dr. Elder has participated in the authorship of many presentations and has been an invited speaker at several industry conferences.